William Mack & Associates
LLY icon

William Mack & Associates’s Eli Lilly LLY Stock Holding History

William Mack & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$117K Buy
+101
New +$119K 0.04% 153

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

William Mack & Associates's LLY Position: Q3 2026 in Review

William Mack & Associates opened a new position in Eli Lilly (LLY) in Q3 2026: 101 shares worth $117K. The stake represents 0.04% of the portfolio and ranks #153 among its holdings.

4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • William Mack & Associates held 101 shares of Eli Lilly worth $117K as of Q3 2026.
  • Eli Lilly was a new William Mack & Associates position in Q3 2026.
  • Eli Lilly made up 0.04% of William Mack & Associates's portfolio in Q3 2026, its #153 holding.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.